Inicio>>Signaling Pathways>> Proteases>> Endogenous Metabolite>>D-Ribose(mixture of isomers)

D-Ribose(mixture of isomers)

Catalog No.GC32012

La D-ribosa (mezcla de isÓmeros) es un potenciador de la energÍa y actÚa como un resto de azÚcar del ATP, y se usa ampliamente como suplemento de terapia metabÓlica para el sÍndrome de fatiga crÓnica o el metabolismo energético cardÍaco.

Products are for research use only. Not for human use. We do not sell to patients.

D-Ribose(mixture of isomers) Chemical Structure

Cas No.: 50-69-1

Tamaño Precio Disponibilidad Cantidad
100mg
46,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

D-Ribose(mixture of isomers) is an energy enhancer, and acts as a sugar moiety of ATP, and widely used as a metabolic therapy supplement for chronic fatigue syndrome or cardiac energy metabolism. D-Ribose(mixture of isomers) is active in protein glycation, induces NF-κB inflammation in a RAGE-dependent manner[1].

D-Ribose(mixture of isomers) is an energy enhancer, and acts as a sugar moiety of ATP, and widely used as a metabolic therapy supplement for chronic fatigue syndrome or cardiac energy metabolism[1].D-Ribose(mixture of isomers) is active in protein glycation, induces NF-κB inflammation in a RAGE-dependent manner[1].

[1]. Hong J, et al. D-ribose induces nephropathy through RAGE-dependent NF-κB inflammation. Arch Pharm Res. 2018 Aug;41(8):838-847.

Reseñas

Review for D-Ribose(mixture of isomers)

Average Rating: 5 ★★★★★ (Based on Reviews and 35 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for D-Ribose(mixture of isomers)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.